← Open Payments lookup

ASHWINI MEHTA: Open Payments

NPI 1174800908 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$40,294 in 90 payments from 14 companies in 2025. Trend: 2023 $2,144 · 2024 $2,784 · 2025 $40,294

Speaker / faculty: $27,738Consulting: $6,773Food & beverage: $2,935Travel & lodging: $2,849
CompanyPaymentsAmount
Madrigal Pharmaceuticals45$39,133
ABBVIE INC.17$355
Gilead Sciences, Inc.9$183
Amgen Inc.2$139
Novo Nordisk Inc2$139
Eisai Inc.3$79
Intra-Sana Laboratories3$72
Ipsen Biopharmaceuticals, Inc3$63
Fujifilm Healthcare Americas Corporation1$28
Sequana Medical US Inc.1$24

Products named: REZDIFFRA, MAVYRET, UPLIZNA, Lenvima, IQIRVO, RELTONE 200 MG, UTASWAKO AFP-L3, GLYCATE.

Industry payments across TX — which companies pay providers there.